Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine

Journal of Rheumatology

Volumn 24, Issue 10, 1997, Pages 1896-1902

  Clegg, Daniel O ^a,k   Dietz, Frederick ^b   Duffy, Joseph ^c   Willkens, Robert F ^d   Hurd, Eric ^e   Germain, Bernard F ^f   Wall, Bruce ^g   Wallace, Daniel J ^h   Bell, Carolyn L ⁱ   Sleckman, Joseph ^j  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Rockford Clinic Ltd   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Arthritis Centers of Texas   (United States)

^f Tampa Medical Group   (United States)

^g Columbus Medical Research Foundation ^*  (United States)

^h CEDARS SINAI MEDICAL CENTER   (United States)

ⁱ University of Wisconsin Health   (United States)

^j UNIVERSITY OF NORTH DAKOTA   (United States)

^k UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

more..

Author keywords

Combination therapy; Hydroxychloroquine; Maintenance therapy; Methotrexate; Rheumatoid arthritis

Indexed keywords

HYDROXYCHLOROQUINE; METHOTREXATE;

ADULT; ALOPECIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SKIN MANIFESTATION; STOMATITIS; TREATMENT PLANNING;

AGED; ARTHRITIS, RHEUMATOID; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME;

EID: 0030862557     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Williams JH: Rheumatoid arthritis: Treatment. In: Schumacher HR Jr, ed. Primer on the Rheumatic Diseases, 10th ed. Atlanta: The Arthritis Foundation, 1993:96-9.
2. Fowler PD, Dawes PT, Sheeran TP, Shadforth MF: Combination therapy in rheumatoid arthritis -Study design (letter). Br J Rheumatol 1987;26:314-5
3. Csuka M, Carrera GF, McCarty DJ: Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. JAMA 1986;255:2315-9.
4. Bitter T: Combined disease-modifying chemotherapy for intractable rheumatoid arthritis. Clin Rheum Dis 1984;10:417-28.
5. Wilske KR, Healey LA: Remodeling the pyramid - A concept whose time has come. J Rheumatol 1989;16:565-7.
6. van der Heide A, Jacobs JWG, Bijlsma JWJ, et al: The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
7. DeVita VT Jr: Principles of chemotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th ed. Philadelphia: JB Lippincott, 1993:276-92.
8. Kremer JM, Rynes RI, Bartholomew LE: Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy. Double-blind study. Am J Med 1987;82:781-6.
9. Felson DT, Anderson JJ, Meenan RF: Use of short-term efficacy/ toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials. Arthritis Rheum 1992;35:1117-25.
10. Fries JF, Williams CA, Ramey D, Bloch DA: The relative toxicity of disease-modifying antirheumatic drugs. Arthritis Rheum 1993;36:297-306.
11. Weinblatt ME, Coblyn JS, Fox DA, et al: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
12. Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 1959;2:16-20.
13. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
14. Pinals RS, Masi AT, Larsen RA, The Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15.
15. Kalbfleisch J, Prentice R: The Statistical Analysis of Failure Time Data. New York: John Wiley, 1980.
16. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39.
17. SAS/STAT User's Guide, version 6, 4th ed. Cary, NC: SAS Institute, 1990.
18. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York: John Wiley, 1981.
19. Felson DT, Anderson JJ, Boers M, et al: American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
20. Trnavský, Gatterová J, Lindušková M, Pelišková Z: Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol 1993;52:292-6.
21. O'Dell JR, Haire CE, Erikson N, et al: Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.
22. Paulus HE, Egger MJ, Ward JR, Williams HJ: Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
23. ten Wolde S, Breedveld FC, Hermans J, et al: Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis. Lancet 1996;347:347-52.
24. Fries JF, Singh G, Lenert L, Furst DE: Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritis. Arthritis Rheum 1990;33:1611-9.
25. Phillips CA, Cera PJ, Mangan TF, Newman ED: Clinical liver disease in patients with rheumatoid arthritis taking methotrexate. J Rheumatol 1992;19:229-33.
26. Easterbrook M: The ocular safety of hydroxychloroquine. Semin Arthritis Rheum 1993;(suppl 1)23:62-7.
27. Easterbrook M: Ocular effects and safety of antimalarial agents. Am J Med 1988;85:23-9.
28. Tett SE, Cutler DJ, Day RO, Brown KF: Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 1989;27:771-9.